{
    "eid": "2-s2.0-85141503597",
    "title": "In Schizophrenia, Chronic Fatigue Syndrome-and Fibromyalgia-Like Symptoms are Driven by Breakdown of the Paracellular Pathway with Increased Zonulin and Immune Activation-Associated Neurotoxicity",
    "cover-date": "2023-02-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Neuroscience (all)",
            "@code": "2800",
            "@abbrev": "NEUR"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "bacterial translocation",
        "Chronic fatigue syndrome",
        "inflammation",
        "myalgic encephalomyelitis",
        "neuro-immune",
        "oxidative stress"
    ],
    "authors": [
        "Michael Maes",
        "Laura Andr\u00e9s-Rodr\u00edguez",
        "Aristo Vojdani",
        "Sunee Sirivichayakul",
        "Decio S. Barbosa",
        "Buranee Kanchanatawan"
    ],
    "citedby-count": 1,
    "ref-count": 36,
    "ref-list": [
        "Schizophrenia in Thailand: Prevalence and burden of disease",
        "How to construct a bottom-up nomothetic network model and disclose novel nosological classes by integrating risk resilience and adverse out-come pathways with the phenome of Schizophrenia",
        "Lowered antiox-idant defenses and increased oxidative toxicity are hallmarks of deficit schizophrenia: A nomothetic network psychiatry approach",
        "How to construct neuroscience-informed psychiatric classification? Towards nomothetic networks psychia-try",
        "Schizophrenia phenome-nology revisited: Positive and negative symptoms are strongly related reflective manifestations of an underlying single trait indicat-ing overall severity of schizophrenia",
        "Construc-tion of a neuro-immune-cognitive pathway-phenotype underpin-ning the phenome of deficit Schizophrenia",
        "In (deficit) schizophrenia, a general cognitive decline partly mediates the effects of neuro-immune and neuro-oxidative toxicity on the symptomatome and quality of life",
        "Supervised machine learning to decipher the complex associations between neuro-immune biomarkers and quality of life in schizophrenia",
        "Inflammatory and oxidative pathways are new drug targets in multiple episode schizophrenia and leaky gut, klebsiella pneumoniae, and C1q immune complexes are additional drug targets in first episode Schizophrenia",
        "Physio-somatic symptoms in schizophrenia: Association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway",
        "Chronic fatigue and fibromyalgia symptoms are key components of deficit schizophrenia and are strongly associated with activated immune-inflammatory pathways",
        "Chronic fatigue syndrome and fibromyalgia-like symptoms are an integral compo-nent of the phenome of schizophrenia: Neuro-immune and opioid system correlates",
        "A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale)",
        "The brief psychiatric rating scale",
        "Positive and negative syndromes in schizophrenia as a function of chronicity",
        "The scale for the assessment of negative symptoms (SANS): Conceptual and theoretical foundations",
        "A rating scale for depression",
        "Study protocol for the World Health Organization project to de-velop a Quality of Life assessment instrument (WHOQOL)",
        "Upregu-lation of the intestinal paracellular pathway with breakdown of tight and adherens junctions in deficit Schizophrenia",
        "Executive functioning in schizophre-nia",
        "The Microbiota-Gut-Immune-Glia (MGIG) axis in major depression",
        "Haptoglobin polymorphism and schizophrenia: Genetic variation on chromosome 16",
        "Acute phase proteins in schizophrenia, mania and major depression: Modulation by psy-chotropic drugs",
        "Increased serum IgA and IgM against LPS of enterobacteria in Chronic Fatigue Syndrome (CFS): Indication for the involvement of gram-negative enterobac-teria in the etiology of CFS and for the presence of an increased gut-intestinal permeability",
        "Normalization of leaky gut in Chronic Fatigue Syndrome (CFS) is accompanied by a clinical improvement: Effects of age, duration of illness and the translocation of LPS from gram-negative bacteria",
        "Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexes",
        "High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal",
        "HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as bi-omarkers of neuroinflammation and progression to neurodegenera-tion in Alzheimer\u2019s disease",
        "High mobility group protein 1 and dickkopf-related protein 1 in Schizophrenia and treatment-resistant Schizophrenia: Associations with interleu-kin-6, symptom domains, and neurocognitive impairments",
        "Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neu-roimmune characteristics",
        "Environmental, neuro-immune, and neuro-oxidative stress interactions in chronic fatigue syndrome",
        "Diagnostic task specific activations in functional MRI and aberrant connectivity of insula with middle frontal gyrus can inform the differential diagnosis of psychosis"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Loma Linda",
            "@id": "60113483",
            "affilname": "Loma Linda University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60113483",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Plovdiv",
            "@id": "60031890",
            "affilname": "Medical University of Plovdiv",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031890",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Londrina",
            "@id": "60027866",
            "affilname": "Universidade Estadual de Londrina",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027866",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Beverly Hills",
            "@id": "60009330",
            "affilname": "Immunosciences Laboratories, Inc.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009330",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Esplugues de Llobregat",
            "@id": "118363155",
            "affilname": "Institut de Recerca Sant Joan de D\u00e9u",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/118363155",
            "affiliation-country": "Spain"
        },
        {
            "affiliation-city": "Phoenix",
            "@id": "101987125",
            "affilname": "LLC",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/101987125",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "Asahi Glass Foundation",
        "Chulalongkorn University"
    ]
}